362 related articles for article (PubMed ID: 27346140)
1. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC
HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140
[TBL] [Abstract][Full Text] [Related]
2. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma.
Lencioni R; Crocetti L; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542
[TBL] [Abstract][Full Text] [Related]
3. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
[TBL] [Abstract][Full Text] [Related]
4. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
5. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
[TBL] [Abstract][Full Text] [Related]
6. Local ablation for hepatocellular carcinoma.
Boyvat F
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():55-9. PubMed ID: 24635794
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P
Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870
[TBL] [Abstract][Full Text] [Related]
8. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T
J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
Sutter O; Calvo J; N'Kontchou G; Nault JC; Ourabia R; Nahon P; Ganne-Carrié N; Bourcier V; Zentar N; Bouhafs F; Sellier N; Diallo A; Seror O
Radiology; 2017 Sep; 284(3):877-886. PubMed ID: 28453431
[TBL] [Abstract][Full Text] [Related]
10. Ablation Zone Involution of Liver Tumors Is Faster in Patients Treated with Irreversible Electroporation Than Microwave Ablation.
Ridouani F; Ghosn M; Cornelis F; Petre EN; Hsu M; Moskowitz CS; Kingham PT; Solomon SB; Srimathveeravalli G
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577800
[No Abstract] [Full Text] [Related]
11. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis.
Cheng RG; Bhattacharya R; Yeh MM; Padia SA
J Vasc Interv Radiol; 2015 Aug; 26(8):1184-8. PubMed ID: 26119204
[TBL] [Abstract][Full Text] [Related]
12. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization.
Si ZM; Wang GZ; Qian S; Qu XD; Yan ZP; Liu R; Wang JH
J Vasc Interv Radiol; 2016 Oct; 27(10):1577-83. PubMed ID: 27103146
[TBL] [Abstract][Full Text] [Related]
13. Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier?
Thamtorawat S; Hicks RM; Yu J; Siripongsakun S; Lin WC; Raman SS; McWilliams JP; Douek M; Bahrami S; Lu DS
J Vasc Interv Radiol; 2016 May; 27(5):623-30. PubMed ID: 27013403
[TBL] [Abstract][Full Text] [Related]
14. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
[TBL] [Abstract][Full Text] [Related]
15. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study.
Cillo U; Noaro G; Vitale A; Neri D; D'Amico F; Gringeri E; Farinati F; Vincenzi V; Vigo M; Zanus G;
HPB (Oxford); 2014 Nov; 16(11):979-86. PubMed ID: 24750429
[TBL] [Abstract][Full Text] [Related]
17. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
Kalra N; Gupta P; Gorsi U; Bhujade H; Chaluvashetty SB; Duseja A; Singh V; Dhiman RK; Chawla YK; Khandelwal N
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):584-590. PubMed ID: 30697637
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
Mafeld S; Wong JJ; Kibriya N; Stenberg B; Manas D; Bassett P; Aslam T; Evans J; Littler P
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):577-583. PubMed ID: 30465255
[TBL] [Abstract][Full Text] [Related]
19. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.
Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707
[TBL] [Abstract][Full Text] [Related]
20. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]